Modulation of Immune Responses by Epstein-Barr Virus

Rowe, Martin (Principal Investigator)
Hislop, Andrew (Co-Investigator)

Short title	Modulation of Immune Responses by Epstein-Barr Virus
Status	Finished
Effective start/end date	1/06/08 → 31/05/11

Funding

Wellcome Trust

2 Article

Epstein-Barr Virus Evades CD4 T Cell Responses in Lytic Cycle through BZLF1-mediated Downregulation of CD74 and the Cooperation of vBcl-2.
Zuo, J., Thomas, W., Haigh, T., Fitzsimmons, L., Long, H., Hislop, A., Taylor, G. & Rowe, M., 1 Dec 2011, In: PLoS pathogens. 7, 12, p. e1002455
Research output: Contribution to journal › Article › peer-review

Open Access
File
44 Citations (Scopus)

262 Downloads (Pure)
The Epstein-Barr virus G-protein-coupled receptor contributes to immune evasion by targeting MHC class I molecules for degradation.
Zuo, J., Currin, A., Griffin, B., Shannon-Lowe, C., Thomas, W., Ressing, M., Wiertz, E. & Rowe, M., 1 Jan 2009, In: PLoS pathogens. 5, 1, p. e1000255
Research output: Contribution to journal › Article › peer-review

Open Access
File
110 Citations (Scopus)

281 Downloads (Pure)